NAV
₹12.2500
as of 30 Sept 2026
Expense Ratio
0.96%
Lumpsum returns (CAGR)
- 1Y
- +26.55%
- 3Y
- —
- 5Y
- —
- Since Inception
- +11.83%
SIP returns (XIRR)
- 1Y
- +29.48%
- 3Y
- —
- 5Y
- —
- Since Inception
- +21.22%
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology63.27%
- Healthcare Services25.70%
- Chemicals & Petrochemicals3.04%
- Insurance1.40%
- Retailing0.71%
- IT - Services0.46%
Each sector links to the mutual funds most exposed to it.
Thinking about PGIM India Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with PGIM India Healthcare Fund - Regular Plan - Growth Option
- 1Divi'S Laboratories Ltd.10.85%
- 2Sun Pharmaceutical Industries Ltd.10.74%
- 3Torrent Pharmaceuticals Ltd.8.86%
- 4Max Healthcare Institute Ltd.4.96%
- 5Ajanta Pharma Ltd.4.83%
- 6Manipal Health Enterprises Ltd.4.12%
- 7Mankind Pharma Ltd.4.07%
- 8Rubicon Research Ltd.4.01%
- 9Dr. Lal Path Labs Ltd.3.93%
- 10Neuland Laboratories Ltd.3.26%
What this fund does
PGIM India Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
PGIM India Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by PGIM India Mutual Fund. The fund has been operational for over 12 years. The current expense ratio is 0.96%.